Literature DB >> 2613360

Use of hepatocytes in adhesion and suspension cultures for liver support bioreactors.

J Gerlach1, K Klöppel, H H Schauwecker, R Tauber, C Müller, E S Bücherl.   

Abstract

Hepatocyte cultivation in bioreactors for hybrid liver support systems is possible under two conditions: attached to a substrate like membranes or microcarriers or in suspension culture. To compare the ammonia metabolism of hepatocytes cultivated under these two conditions, cultures of primary seeded rat hepatocytes were cultivated either attached to collagen coated tissue culture plastic or as a suspension culture. During the time course of culture, the ability of hepatocytes to reduce the ammonia content of the medium decreased in both adhesion and suspension cultures, though to different extents. In suspension cultures, ammonia content was reduced from 350 microM to about 100 microM (day 4) and to about 180 microM (day 6). No significant reduction was seen on day 8 of culture. In contrast, hepatocytes attached to collagen coated dishes remained viable and functional for at least 8 days after plating, reducing ammonia content from 350 microM to 70 microM (day 4), 90 microM (day 6) and 180 microM (day 8). The period of useful metabolism of hepatocytes in bioreactors for hybrid liver support systems appears to depend on the culture conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613360

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Culture model for primary hepatocytes.

Authors:  J C Gerlach; P Neuhaus
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

Review 2.  Concept for modular extracorporeal liver support for the treatment of acute hepatic failure.

Authors:  I M Sauer; P Neuhaus; J C Gerlach
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

3.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

Authors:  S L Nyberg; R P Remmel; H J Mann; M V Peshwa; W S Hu; F B Cerra
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

4.  Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.

Authors:  Eloy Erro; James Bundy; Isobel Massie; Sherri-Ann Chalmers; Aude Gautier; Spyridon Gerontas; Mike Hoare; Peter Sharratt; Sarah Choudhury; Marcin Lubowiecki; Ian Llewellyn; Cécile Legallais; Barry Fuller; Humphrey Hodgson; Clare Selden
Journal:  Biores Open Access       Date:  2013-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.